|
KEGG_PATHWAYS_IN_CANCER
|
17
|
1.53E-07
|
1.63E-04
|
|
KEGG_PROSTATE_CANCER
|
10
|
2.46E-07
|
1.63E-04
|
|
KEGG_THYROID_CANCER
|
6
|
5.01E-06
|
2.22E-03
|
|
PID_WNT_CANONICAL_PATHWAY
|
4
|
1.05E-05
|
3.25E-03
|
|
KEGG_ENDOMETRIAL_CANCER
|
7
|
1.22E-05
|
3.25E-03
|
|
PID_BETACATENIN_DEG_PATHWAY
|
4
|
3.65E-05
|
7.14E-03
|
|
KEGG_MELANOMA
|
7
|
3.76E-05
|
7.14E-03
|
|
KEGG_GLIOMA
|
7
|
4.44E-05
|
7.38E-03
|
|
REACTOME_CELL_CYCLE_MITOTIC
|
12
|
5.20E-05
|
7.68E-03
|
|
KEGG_BLADDER_CANCER
|
5
|
1.10E-04
|
1.47E-02
|
|
KEGG_NON_SMALL_CELL_LUNG_CANCER
|
6
|
1.56E-04
|
1.88E-02
|
|
PID_HES_HEYPATHWAY
|
5
|
1.76E-04
|
1.88E-02
|
|
KEGG_COLORECTAL_CANCER
|
6
|
1.84E-04
|
1.88E-02
|
|
REACTOME_SIGNALING_BY_FGFR
|
7
|
2.12E-04
|
2.02E-02
|
|
KEGG_ACUTE_MYELOID_LEUKEMIA
|
6
|
2.90E-04
|
2.41E-02
|
|
PID_SMAD2_3NUCLEARPATHWAY
|
6
|
3.35E-04
|
2.47E-02
|
|
ST_WNT_BETA_CATENIN_PATHWAY
|
4
|
3.53E-04
|
2.47E-02
|
|
BIOCARTA_GSK3_PATHWAY
|
4
|
3.53E-04
|
2.47E-02
|
|
REACTOME_MITOTIC_G2_G2_M_PHASES
|
5
|
3.90E-04
|
2.60E-02
|
|
REACTOME_SIGNALING_BY_FGFR_IN_DISEASE
|
7
|
4.24E-04
|
2.68E-02
|
|
PID_MTOR_4PATHWAY
|
6
|
5.70E-04
|
3.29E-02
|
|
BIOCARTA_G1_PATHWAY
|
4
|
5.94E-04
|
3.29E-02
|
|
SA_G1_AND_S_PHASES
|
3
|
6.95E-04
|
3.29E-02
|
|
REACTOME_G0_AND_EARLY_G1
|
3
|
6.95E-04
|
3.29E-02
|
|
PID_TCRRASPATHWAY
|
3
|
6.95E-04
|
3.29E-02
|
|
PID_RB_1PATHWAY
|
6
|
7.27E-04
|
3.29E-02
|
|
PID_IL4_2PATHWAY
|
5
|
7.61E-04
|
3.29E-02
|
|
REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE
|
7
|
7.77E-04
|
3.29E-02
|
|
KEGG_RENAL_CELL_CARCINOMA
|
6
|
8.17E-04
|
3.29E-02
|
|
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR
|
6
|
8.17E-04
|
3.29E-02
|
|
REACTOME_CELL_CYCLE
|
12
|
9.15E-04
|
3.54E-02
|
|
REACTOME_SIGNALING_BY_ERBB2
|
6
|
1.27E-03
|
4.21E-02
|
|
KEGG_CHRONIC_MYELOID_LEUKEMIA
|
6
|
1.27E-03
|
4.21E-02
|
|
BIOCARTA_CELLCYCLE_PATHWAY
|
3
|
1.44E-03
|
4.55E-02
|
|
PID_FOXM1PATHWAY
|
4
|
1.66E-03
|
4.96E-02
|
|
REACTOME_SIGNALING_BY_PDGF
|
6
|
1.89E-03
|
4.96E-02
|
|
REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS
|
3
|
1.94E-03
|
4.96E-02
|
|
PID_E2F_PATHWAY
|
5
|
1.97E-03
|
4.96E-02
|
|
PID_ER_NONGENOMIC_PATHWAY
|
4
|
1.98E-03
|
4.96E-02
|
|
REACTOME_SIGNALING_BY_EGFR_IN_CANCER
|
6
|
2.07E-03
|
5.10E-02
|
|
BIOCARTA_P53_PATHWAY
|
3
|
2.55E-03
|
5.84E-02
|
|
KEGG_PANCREATIC_CANCER
|
5
|
2.77E-03
|
6.14E-02
|
|
PID_PI3KPLCTRKPATHWAY
|
4
|
3.64E-03
|
7.44E-02
|
|
PID_AR_TF_PATHWAY
|
4
|
3.64E-03
|
7.44E-02
|
|
BIOCARTA_IGF1R_PATHWAY
|
3
|
4.07E-03
|
8.07E-02
|
|
REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR
|
3
|
4.07E-03
|
8.07E-02
|
|
KEGG_ERBB_SIGNALING_PATHWAY
|
5
|
4.19E-03
|
8.07E-02
|
|
REACTOME_SIGNALING_BY_SCF_KIT
|
5
|
4.61E-03
|
8.63E-02
|
|
REACTOME_SIGNALING_BY_ERBB4
|
5
|
4.61E-03
|
8.63E-02
|
|
REACTOME_UNFOLDED_PROTEIN_RESPONSE
|
4
|
4.74E-03
|
8.76E-02
|
|
BIOCARTA_WNT_PATHWAY
|
3
|
6.04E-03
|
9.36E-02
|
|
BIOCARTA_BAD_PATHWAY
|
3
|
6.04E-03
|
9.36E-02
|
|
BIOCARTA_IGF1MTOR_PATHWAY
|
3
|
6.04E-03
|
9.36E-02
|
|
PID_AURORA_A_PATHWAY
|
3
|
6.04E-03
|
9.36E-02
|
|
WNT_SIGNALING
|
4
|
6.05E-03
|
9.36E-02
|
|
PID_AR_PATHWAY
|
4
|
6.79E-03
|
0.10
|
|
REACTOME_SIGNALLING_BY_NGF
|
7
|
7.50E-03
|
0.10
|
